z-logo
open-access-imgOpen Access
Shape-parameterized diffuse optical tomography holds promise for sensitivity enhancement of fluorescence molecular tomography
Author(s) -
Linhui Wu,
Wenbo Wan,
Xin Wang,
Zhongxing Zhou,
Jiao Li,
Limin Zhang,
Huijuan Zhao,
Feng Gao
Publication year - 2014
Publication title -
biomedical optics express
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.362
H-Index - 86
ISSN - 2156-7085
DOI - 10.1364/boe.5.003640
Subject(s) - diffuse optical imaging , voxel , tomography , optical tomography , inverse problem , parameterized complexity , computer science , robustness (evolution) , sensitivity (control systems) , optical coherence tomography , optics , image resolution , artificial intelligence , computer vision , biological system , physics , algorithm , mathematics , chemistry , mathematical analysis , biochemistry , electronic engineering , biology , gene , engineering
A fundamental approach to enhancing the sensitivity of the fluorescence molecular tomography (FMT) is to incorporate diffuse optical tomography (DOT) to modify the light propagation modeling. However, the traditional voxel-based DOT has been involving a severely ill-posed inverse problem and cannot retrieve the optical property distributions with the acceptable quantitative accuracy and spatial resolution. Although, with the aid of an anatomical imaging modality, the structural-prior-based DOT method with either the hard- or soft-prior scheme holds promise for in vivo acquiring the optical background of tissues, the low robustness of the hard-prior scheme to the segmentation error and inferior performance of the soft-prior one in the quantitative accuracy limit its further application. We propose in this paper a shape-parameterized DOT method for not only effectively determining the regional optical properties but potentially achieving reasonable structural amelioration, lending itself to FMT for comparably improved recovery of fluorescence distribution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here